Person

Daniel M. Junius

Director, Idexx Laboratories

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$12.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 4, 2026IDXXSale700$705.78$494K
Nov 4, 2026IDXXSale500$701.69$351K
May 13, 2025IDXXSale2,683$506.41$1.4M
Feb 16, 2023IDXXSale2,187$511.68$1.1M
Dec 5, 2022IDXXSale3,046$424.91$1.3M
Aug 10, 2021IDXXSale2,402$679.58$1.6M
May 21, 2021IDXXSale2,500$539.57$1.3M
Feb 22, 2021IDXXSale10$539.19$5K
Feb 22, 2021IDXXSale1,888$538.57$1.0M
Aug 20, 2020IDXXSale3,722$382.61$1.4M
May 19, 2020IDXXSale4,000$295.61$1.2M
Feb 28, 2018IDXXSale2,974$190.06$565K
Feb 8, 2017IDXXSale3,000$141.75$425K

SEC reporting-owner ID (CIK) 1094159 · all filings on EDGAR

Daniel M. Junius (IDXX) | USBoard